Intrinsic Value of S&P & Nasdaq Contact Us

4Front Ventures Corp. FFVWF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • USD

SharesGrow Score
19/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

4Front Ventures Corp. (FFVWF) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 18/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
19/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — FFVWF

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.14
Book Value / Share$0.00
Revenue / Share$0.15
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2014 $-0.48 $8.71K $-182.62K -2097.3%
2015 $-0.37 $0.00 $-140.33K -
2016 $0.05 $2.01M $-157K -7.8%
2017 $-0.11 $3.83M $-3.02M -78.8%
2018 $-0.08 $4.06M $-52.55M -1295.7%
2019 $-0.43 $19.03M $-182.01M -956.3%
2020 $-0.09 $57.64M $-47.05M -81.6%
2021 $-0.06 $104.57M $-38.31M -36.6%
2022 $-0.07 $107.66M $-46.9M -43.6%
2023 $-0.14 $97.44M $-91.65M -94.1%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message